Cellebrite DI Forecast, price target & analysts
Cellebrite DI Target price 2026 - Analyst rating & recommendation
Cellebrite DI Classifications & Recommendation
Cellebrite DI Price Target
| Target Price | $15.30 |
| Price | $10.93 |
| Potential |
39.98%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Cellebrite DI 2027 .
The average Cellebrite DI target price is $15.30.
This is
39.98%
register free of charge
$21.43
96.07%
register free of charge
$12.63
15.51%
register free of charge
|
|
| A rating was issued by 15 analysts: 14 Analysts recommend Cellebrite DI to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cellebrite DI stock has an average upside potential 2027 of
39.98%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 475.68 | 567.78 |
| 18.56% | 19.36% | |
| EBITDA Margin | 16.47% | 27.90% |
| 2.11% | 69.39% | |
| Net Margin | 16.36% | 25.56% |
| 123.19% | 56.26% |
11 Analysts have issued a sales forecast Cellebrite DI 2026 . The average Cellebrite DI sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Cellebrite DI EBITDA forecast 2026. The average Cellebrite DI EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Cellebrite DI Analysts have issued a net profit forecast 2026. The average Cellebrite DI net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.31 | 0.58 |
| 122.96% | 87.10% | |
| P/E | 18.89 | |
| EV/Sales | 4.06 |
11 Analysts have issued a Cellebrite DI forecast for earnings per share. The average Cellebrite DI EPS is
This results in the following potential growth metrics and future valuations:
Current Cellebrite DI Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DA Davidson |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| DA Davidson |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| DA Davidson |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| DA Davidson |
Locked
➜
Locked
|
Locked | May 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
DA Davidson:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
DA Davidson:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
DA Davidson:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
DA Davidson:
Locked
➜
Locked
|
May 27 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
